To The Moon

Palantir Technologies (NYSE: PLTR) plunged 10.08% on Wednesday, closing at $112.06, following news that CEO Alex Karp plans to sell more than $1 billion worth of his shares. Adding to investor concerns, reports surfaced that the Pentagon is considering budget cuts over the next five years, which could impact government contracts—one of Palantir's biggest revenue drivers.

Palantir Technologies Inc. (PLTR)

Why Did Palantir Drop?

1. CEO Stock Sale Signals Potential Overvaluation

   Insider sales, especially of this magnitude, often raise red flags. While Karp may have personal reasons for selling, investors view large insider sales as a lack of confidence in future stock performance. Given Palantir’s sharp rally over the past year, many already see the stock as overvalued, making Karp’s decision unsurprising. If I were in his position, I’d likely sell as well.

2. Pentagon Budget Cuts Threaten Growth

   Palantir relies heavily on government contracts, and any reduction in defense spending could hurt its revenue and growth prospects. While the company has been expanding its commercial business, government contracts still make up a significant portion of its income. A slowdown in defense spending could lead to fewer contract wins or delays in existing agreements.

3. Stock Still Overpriced Despite Drop

   Even after this decline, Palantir remains far from its 52-week low of $20.33, meaning it still has room to fall. The stock has been riding the AI and big data hype, but its fundamentals may not fully justify its high valuation.

Will Palantir Drop Below $100?

• If selling pressure continues and investor sentiment remains weak, PLTR could test key psychological support at $100.

• A further decline could be triggered by broader market weakness, disappointing earnings, or additional insider selling.

• The stock is still trading at a premium, so a pullback to a more reasonable valuation wouldn’t be surprising.

Final Thoughts

While Palantir has strong long-term potential in AI and data analytics, the combination of an insider stock sale, concerns about government spending, and an overextended valuation makes it a risky buy at current levels. Until the stock finds stronger support or shows better fundamentals, I won’t be buying.